Metagenomic Sequencing Market Overview 2020: In-Depth Analysis With Impact of Covid 19, Types, Opportunities, Revenue and Forecast to 2023
MRFR has recorded a research on “Metagenomic Sequencing Market
2023” and also established detailed analysis on market trends, market overview
Market
Analysis :
Various
factors are propelling the metagenomic sequencing market growth. These factors,
as stated by the latest MRFR report, include growing awareness about genetic
disorders, improved genomic tools, advanced technological platforms, funding
and favorable initiatives undertaken by private bodies and government for large-scale
sequencing projects, declining cost of sequencing, and recovery of new drugs.
Additional factors propelling market growth include high throughput screening
methods, development of cost-effective technologies (next-generation
sequencing), increasing research and development for identifying new enzymes
and antibiotics, and improved bioinformatics.
The
global Metagenomic Sequencing Industry is predicted to grow at a 6.5% CAGR over
the forecast period (2017-2023), states the new Market Research Future (MRFR)
report. Metagenomics, simply put, is a molecular tool that is used for
analyzing DNA that is acquired from environmental samples to study the
community of microorganisms present in their natural habitat devoid of the need
to obtain pure cultures.
This
method along with offering species identification, classification, as well as
quantitation of microbes, will also at the same time offer information for
functional analysis of genes with the help of metabolic pathway analysis and
gene ontology. Its key benefit is that metagenomics allows the study and
discovery of microbial genomes that otherwise would be intractable owing to
cultivation difficulties.
Key
Players:
include Knome Inc. (US), Helicos
BioSciences (US), Macrogen Inc. (South Korea), DNAStar Inc. (US), Agilent
Technologies Inc. (US), CLC Bio (Qiagen) (Denmark), Oxford Nanopore
Technologies Inc. (UK), Thermo Fisher Scientific Inc. (US), Biomatters Ltd.
(New Zealand), Beijing Genomics Institute (China), Pacific Biosciences (US),
COSMOSID (US), GenapSys, Inc. (US), Freenome Inc. (US), Quest Diagnostics
Incorporated (US), Second Genome Therapeutics (US), SciGenom Labs Pvt. Ltd.
(India), F Hoffman-La Roche Ltd. (Switzerland), The Mitre Corporation (US),
Aperiomics, Inc. (US), Illumina Inc. (US), Enterome Bioscience (France), and
Biotech AG (Germany).
Market
Segmentation :
· The MRFR report provides a complete segmental analysis of the Metagenomic Sequencing Market Applications report on the basis of end user, application, and technology.
· Based on technology, the metagenomic sequencing market is segmented into bioinformatics, sequencing, and others.
· Based on application, the metagenomic sequencing market is segmented into agriculture, ecology, biofuel, biotechnology, gut microbe characterization, environmental remediation, and infectious disease diagnosis.
· Based on end user, the metagenomic sequencing market is segmented into specialized clinics, research institutes, hospitals, and others.
Regional
Analysis:
By
region, the metagenomic sequencing market report covers the latest trends and
growth opportunities across the Asia Pacific, Europe, the Americas, and the
Middle East and Africa. Of these, the Americas will lead the market over the
forecast period. Factors aiding growth in the region include advancements in
technology in the next-generation sequencing methods and its increasing
applications.
The
metagenomic sequencing market in Europe is predicted to have the second-largest
share in the market over the forecast period. Factors aiding growth in the
region include increasing investment by government and hospital facilities for
better healthcare, increasing use of NGS techniques by research laboratories,
low cost of sequencing, and growing partnerships and collaborations.
Access
Full Report Details @ https://www.marketresearchfuture.com/reports/metagenomic-sequencing-market-5598
The
metagenomic sequencing market in the APAC region is predicted to grow in the
fastest pace over the forecast period. Factors aiding growth in the region
include increasing incidence of genetic disorders worldwide, and affordable
healthcare & research.
Related
Reports:
Cell Therapy
Market Research Report- Global Forecast till 2023
https://www.marketresearchfuture.com/infographics/cell-therapy-market
Carotid Artery Disease Market Research Report - Global
Forecast till 2023
https://www.marketresearchfuture.com/infographics/carotid-artery-disease-market
Related Videos:
Veterinary Imaging Market Insights 2019-2023
https://www.marketresearchfuture.com/videos/veterinary-imaging-market
Comments
Post a Comment